CD44 and ovarian neoplasm: Moreover, transfection of CD44+⁄CD117+ cells enriched from human primary ovarian tumor tissues with miR-199a, significantly decreased CD44 mRNA and protein expression while significantly affecting cell cycle regulation, suppressing proliferation, and increasing chemosensitivity of ovarian CICs.